Elsevier has approached academic institutions and researchers in Finland. The letter states Elsevier’s view on the negotiations between the FinELib consortium and Elsevier. The crucial issues for the negotiations are cost development and open access. The FinELib consortium’s view differs from Elsevier’s on both issues.→ Read more
There has been no advancement in FinELib’s Elsevier negotiations in June. However, the commitment of the Finnish academic society to the goals of the negotiations is strong. This is clearly seen in two recent statements:→ Read more
FinELib and Elsevier negotiators met recently to continue the negotiations started in 2016. FinELib’s requirements remain unchanged: Affordable prices for accessing Elsevier’s journals (SD Freedom collection) and advancing open access. Unfortunately the first meeting showed that Elsevier is not willing to develop open access business models.→ Read more
Take advantage of
open access benefits
During negotiations, open access benefits have been agreed upon regarding the journals of the following publishers:
American Chemical Society | Elsevier | Emerald | IEEE | Royal Society of Chemistry | Sage | Science Advances | Springer Nature | Wiley | Wolters Kluwer/Lippincott
More information about publisher- and organisation-specific open access benefits is also available from your own library.